glp 1 compounded tirzepatide GLP-1 & GIP Compounded Tirzepatide (GLP-1/GIP)

Results will be submitted for publication in an international peer-reviewed scientific journal

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

"

GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy. These drugs hold the potential to help address what continues to be an increasing obesity problem in the US. A 2024 []

Rocio Salas-Whalen, an expert in obesity medicine, delivers the real-world strategies that have helped thousands of patients achieve health goals that once felt out of reach

Weight-loss pens have been available on the pharmaceutical market for about a decade, initially appearing internationally